Evidence map›Paper›PMID 31329965›Full record

Trial reportRheumatology (Oxford, England)2019

Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis.

Isabel Mortimer, Lesley-Anne Bissell, Elizabeth M A Hensor, Lukasz Kozera, Sarah L Mackie, Agata N Burska, Jackie L Nam, Helen Keen, Edith Villeneuve, Helena Donica and 5 more

Abstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Rheumatology (Oxford, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Isabel MortimerLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Lesley-Anne BissellLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Elizabeth M A HensorLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Lukasz KozeraLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Sarah L MackieLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Agata N BurskaLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Jackie L NamLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Helen KeenLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Edith VilleneuveLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Helena DonicaDepartment of Biochemical Diagnostics, Medical University of Lublin, Lublin, Poland.
Maya H BuchLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Philip G ConaghanLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Paul EmeryLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.
Ann W MorganLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Jacqueline AndrewsLeeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds.

Funding

Department of Health NIHR-CS-012-016Medical Research Council MR/K015346/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAntirheumatic AgentsArthritis, RheumatoidBiomarkersCardiovascular DiseasesDrug Therapy, CombinationEarly DiagnosisFemaleFollow-Up StudiesHumansInfliximabMaleMethotrexateMethylprednisoloneMiddle AgedAntirheumatic AgentsBiomarkersInfliximabMethotrexateMethylprednisolone

Identifiers

PMID31329965
PMCPMC6735716

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.